Join Morrison Foerster to explore the evolving legal landscape surrounding artificial intelligence in medical devices. This session will focus on product liability considerations and the shifting classification of software as a product.
Presented by Morrison Foerster
MedTech Meets AI: Legal Insights on AI Integration
September 23, 2025
1:00 PM – 2:00 PM
MedTech Meets AI: Legal Insights on AI Integration
September 23, 2025
1:00 PM – 2:00 PM
Erin Bosman, Global Co-Chair of Litigation and founder of the AI practice group at Morrison Foerster, and Brigid Bondoc, FDA and Healthcare Regulatory and Compliance partner, will lead the discussion: “MedTech Meets AI: Legal Insights on AI Integration.”
The presentation will examine the evolving legal framework for artificial intelligence in medical devices. In particular, it will highlight product liability considerations as well as the shifting classification of software as a product. In addition, the speakers will connect these legal issues to the broader business challenges MedTech companies face when adopting AI.
Key Takeaways
- Understand the evolving legal landscape surrounding artificial intelligence in medical devices, including product liability considerations and the reclassification of software as a product.
- Gain insights into the potential business implications for MedTech companies’ use of AI. These include regulatory challenges and emerging risks associated with AI-enabled technologies.
- Learn practical strategies for risk mitigation to help companies navigate compliance and safeguard operations in a rapidly changing environment.
Date: September 23rd, 2025
Time: 1:00 PM -2:00 PM ET
Location: Online
RSVP now to stay ahead of the curve and uncover what’s next for MedTech in today’s dynamic healthcare landscape.
Meet The Speakers
Erin Bosman – Global Co-Chair of Litigation and founder of the AI practice group, Morrison Foerster
Erin Bosman is the global co-chair of Morrison Foerster’s litigation department. Erin is also the founder and co-head of the Artificial Intelligence group and former chair of the Complex Litigation + Advisement practice group. Clients value her business strategy, seeking her comprehensive counsel throughout the product life cycle, especially in high-stakes litigation and product recalls.
Erin’s clients value her litigation acumen, retaining her as national coordinating and trial counsel in class action cases and multijurisdictional and multidistrict proceedings. She navigates complex business relationships and serves as a defense liaison counsel in cases where multiple defendants have conflicting defenses. A skilled negotiator, Erin has a long track record of securing dismissals and favorable settlements for her clients. When trial is needed, her compelling courtroom skills have delivered successful jury verdicts and appellate victories.
Brigid Bondoc – FDA and Healthcare Regulatory and Compliance partner, Morrison Foerster
Brigid is a food, drug, and medical device lawyer who counsels life sciences companies on a wide range of U.S. Food & Drug Administration pre- and post-market regulatory issues.
As the lead of our FDA + Healthcare Regulatory and Compliance Group, Brigid practices across the spectrum of FDA-regulated products, including medical devices, drugs, biologics, cell and gene therapies, food, cosmetics, dietary supplements, tobacco, laboratory-developed tests, in vitro diagnostics, radiation-emitting electronic products, combination products, and products that may not fit neatly into any of these categories. Accordingly, she counsels established and start-up companies in life sciences, healthcare, and consumer products on a wide range of FDA pre- and post-market regulatory issues. Brigid also frequently advises innovative product developers on threshold FDA jurisdictional questions and develops strategies for approval and marketing, while identifying and mitigating regulatory risks.
